NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered Retatrutide from Changsha Xjun Technology? Mail in a sample (US only) and let us test it for free.

Test my supply
79%
Finnrick rating
#169 of 378 Retatrutide vendors
5 of 6 classifiable tests passed
natural 83% · customers 4.5★ (3)
methodology · Purity focus
Finnrick analysis · Retatrutide

Changsha Xjun Technology Retatrutide is mixed: identity held, but one 10 mg vial tested at 98.51% purity with +24% fill. The next result recovered; repeated missing batch IDs and no price/review data keep corroboration thin.

methodology →
vendor intelligence report
Vendor Intelligence Report: Changsha Xjun Technology

eChem captures and chjunxi.com WHOIS show a platform-led operation with no independent public site and unresolved registry identity. The report traces BDO exposure, sales personas, COA-verification gaps, and a Caoquan network lead that does not resolve cleanly.

26 pages5 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$0.38
79%
1
2
Retatrutideselected
$0.90
79%
6
5
PT-141
-
-
0
6
Tesamorelin
$1.60
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%31 Aug 2025: 69%22 Feb 2026: 79%22 Feb 2026: 81%22 Feb 2026: 82%22 Feb 2026: 78%3 Mar 2026: 79%29 Sep 2026: current 79%69%79%79%Aug 25Sep 26
Showing Retatrutide tests only
Changsha Xjun Technology Retatrutide test history
COA-backed lab tests

About Changsha Xjun Technology test results from Finnrick

Changsha Xjun Technology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 7 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Changsha Xjun Technology peptides in this dataset are Retatrutide (6 tests), Tirzepatide (1 test) and Tesamorelin (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 7 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered Retatrutide from Changsha Xjun Technology? Mail in a sample (US only) and let us test it for free.

Test my supply